Sign In
Buy CERT
$8.10
+0.320 (+4.11%)
At Close: Jul 31, 2026
Intech Investment Management LLC Makes New $329,000 Investment in Certara, Inc. $CERT
04:46am, Monday, 01'st Dec 2025
Intech Investment Management LLC bought a new stake in Certara, Inc. (NASDAQ: CERT) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commissio
Touchstone Small Company Fund Q3 2025 Performance Review
09:30am, Thursday, 27'th Nov 2025
The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, 2025. Among the Fund's top-performing sectors in terms of adding value were
Certara, Inc. (CERT) Presents at Stephens Annual Investment Conference 2025 Transcript
04:48pm, Tuesday, 18'th Nov 2025
Certara, Inc. ( CERT ) Stephens Annual Investment Conference 2025 November 18, 2025 2:00 PM EST Company Participants John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Confer
Certara, Inc. (CERT) Presents at Jefferies London Healthcare Conference 2025 Transcript
07:38am, Tuesday, 18'th Nov 2025
Certara, Inc. ( CERT ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants William Feehery - CEO & Director Conference Call Participants David Windley - Jeff
Certara, Inc. (CERT) Q3 2025 Earnings Call Transcript
08:56pm, Thursday, 06'th Nov 2025
Certara, Inc. ( CERT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants William Feehery - CEO & Director John Gallagher - SVP, Principal Accounting Officer & Chief Financial Off
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates
07:55pm, Thursday, 06'th Nov 2025
Certara, Inc. (CERT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.13 per share a year ago.
Certara Reports Third Quarter 2025 Financial Results
04:15pm, Thursday, 06'th Nov 2025
RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal ye
Certara Automates Scientific Workflows with Phoenix® Cloud
08:00am, Tuesday, 04'th Nov 2025
RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio, the first cloud-native module
Certara to Participate in Upcoming Investor Conferences
08:00am, Friday, 31'st Oct 2025
RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the followi
Certara Expands Biosimulation Market with AI-Driven QSP Platform
04:15pm, Thursday, 30'th Oct 2025
RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quanti
Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for
11:07am, Thursday, 30'th Oct 2025
Certara (CERT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Certara Scientists are Among the Topmost Cited Biopharma Researchers
08:00am, Monday, 20'th Oct 2025
RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research.
Why Investors Should Consider Certara Again
05:55pm, Wednesday, 15'th Oct 2025
Certara posted strong Q1 and Q2 results, with revenue growth and non-GAAP EPS exceeding expectations, driven by biosimulation software and services. Certara's AI-enabled platforms, including the upcom
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
08:00am, Friday, 10'th Oct 2025
RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 afte
Final Trade: CERT, GDX, IWM, MPC
06:34pm, Tuesday, 23'rd Sep 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
